Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.4.0.3
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2016
Notes to Financial Statements  
NOTE D - STOCK-BASED COMPENSATION

The fair value of each option grant on the date of grant is estimated using the Black-Scholes option-pricing model.  On the date of grant, the following weighted average assumptions were utilized for options granted during the three months ended March 31, 2015.  There were no option grants during the three months ended March 31, 2016.

 

  Three Months Ended March 31, 2015

 

Risk-free interest rates

Expected option life in years

Expected stock price volatility

Expected dividend yield

1.39%

5 years

30.24%

  -0-

The following table presents information relating to all stock options outstanding and exercisable at March 31, 2016:

 

            Weighted        
        Weighted   Average       Weighted
Range of       Average   Remaining       Average
Exercise   Options   Exercise   Life in   Options   Exercise
    Price       Outstanding       Price           Years       Exercisable       Price    
                     
$0.83 - $2.34   2,410,000   $1.29   3.40   2,410,000   $1.29

 

The Company recorded stock-based compensation of $12,000 and $100,000 for the three months ended March 31, 1016 and March 31, 2015, respectively.  The Company had no unrecognized stock-based compensation cost as of March 31, 2016.  The aggregate intrinsic value of options exercisable at March 31, 2016 was $1,551,000.

During the three month period ended March 31, 2016, the Company's Chief Financial Officer and Executive Vice President exercised stock options to purchase 100,000 shares of the Company's common stock, at an exercise price of $1.59 per share, and 240,000 shares of common stock, at an exercise price of $1.60 per share, respectively.  The options were exercised on a partial cashless (net exercise) basis by delivery to the Company of an aggregate of 249,820 shares of the Company's common stock (Chief Financial Officer – 50,857 shares and Executive Vice President - 198,963 shares) and $60,000.  In addition an aggregate of 22,655 shares (Chief Financial Officer – 5,563 shares and Executive Vice President – 17,092 shares) were delivered to fund payroll withholding taxes on exercise, resulting in net shares of 43,580 and 23,945 issued to the Chief Financial Officer and Executive Vice President, respectively, with respect to such option exercises.  In addition, during the three month period ended March 31, 2016, a consultant to the Company exercised a stock option to purchase 90,000 shares of the Company's common stock, at an exercise price of $1.60 per share.  Such option was exercised on a cashless (net exercise) basis by delivery to the Company of 72,727 shares of common stock resulting in 17,273 net shares issued to the consultant with respect to such option exercise.

During the three month period ended March 31, 2015, the Company granted 5-year stock options to each of its three non-management directors to purchase 35,000 shares of its common stock at an exercise price of $2.34 per share.  Such options vested over a one-year period in four equal quarterly amounts beginning on April 22, 2015, subject to continued service on the Board.

As of March 31, 2016, the following are the outstanding warrants to purchase shares of the Company's common stock:

 

  Number of   Exercise    
  Warrants   Price   Expiration Date
           
  250,000   $2.10   May 21, 2018
  250,000   $1.40   May 21, 2018
  125,000   $2.10    July 26, 2018
  125,000   $1.40    July 26, 2018
Total       750,000        

 

All of the aforementioned warrants were issued to Recognition Interface, LLC in connection with the Company's acquisition of the Mirror Worlds Patent Portfolio (see Note I[2]).